Atypical forms of optic neuritis

Revue Neurologique

Volumn 168, Issue 10, 2012, Pages 697-701

  De Seze, J ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

CRION; Multiple sclerosis; Neuromyelitis optica; Optic neuritis; RION

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; RECURRENT DISEASE; SYSTEMIC DISEASE; VASCULITIS;

EYE INFECTIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NEURITIS; RECURRENCE; SARCOIDOSIS; SJOGREN'S SYNDROME;

EID: 84867547874     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2012.07.013     Document Type: Conference Paper

References (27)

1. C. Arndt, P. Labauge, C. Speeg-Schatz, L. Jeanjean, M. Fleury, and G. Castelnovo Recurrent inflammatory optic neuropathy J Fr Ophtalmol 31 2008 363 367
2. R.W. Beck, P.A. Cleary, M.M. Anderson, J.L. Keltner, W.T. Shults, and D.I. Kaufman A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group N Engl J Med 326 1992 581 588
3. F. Blanc, B. Jaulhac, M. Fleury, J. de Seze, S.J. de Martino, and V. Remy Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients Neurology 69 2007 953 958
4. F. Blanc, L. Ballonzoli, C. Marcel, S. De Martino, B. Jaulhac, and J. de Seze Lyme optic neuritis J Neurol Sci 295 2010 117 119
5. N. Collongues, and J. de Seze Current and future treatment approaches for neuromyelitis optica Adv Neurol 4 2011 111 121
6. B.A. Cree, S. Lamb, K. Morgan, A. Chen, E. Waubant, and C. Genain An open label study of the effects of rituximab in neuromyelitis optica Neurology 64 2005 1270 1272
7. J. de Seze, M. Debouverie, H. Zephir, C. Lebrun, F. Blanc, and V. Bourg Acute fulminant demyelinating disease: a descriptive study of 60 patients Arch Neurol 64 2007 1426 1432
8. J. de Seze, F. Blanc, L. Jeanjean, H. Zephir, P. Labauge, and M. Bouyon Optical coherence tomography in neuromyelitis optica Arch Neurol 65 2008 20 23
9. J. de Seze, C. Arndt, L. Jeanjean, H. Zephir, F. Blanc, and P. Labauge Relapsing inflammatory optic neuritis: is it neuromyelitis optica? Neurology 70 2008 2075 2076
10. J. de Seze, and C. Arndt Recurrent inflammatory optic neuritis and neuromyelitis optica Rev Neurol 166 2010 966 969
11. S. Delalande, J. de Seze, A.L. Fauchais, E. Hachulla, T. Stojkovic, and D. Ferriby Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients Medicine (Baltimore) 83 2004 280 291
12. M. Govoni, M. Padovan, N. Rizzo, and F. Trotta CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnosis assessment and therapeutic approach CNS Drugs 15 2001 597 607
13. S. Jarius, J. Frederikson, P. Waters, F. Paul, G. Akman-Demir, and R. Marignier Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis J Neurol Sci 298 2010 158 162
14. S. Jarius, and B. Wildemann AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance Rev Neurol Dis 6 2010 383 392
15. D. Kidd, B. Burton, G.T. Plant, and E.M. Graham Chronic relapsing inflammatory optic neuropathy (CRION) Brain 126 2003 276 284
16. V.A. Lennon, D.M. Wingerchuk, T.J. Kryzer, S.J. Pittock, C.F. Lucchinetti, and K. Fujihara A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis Lancet 364 2004 2106 2112
17. C.F. Lucchinetti, L. Kiers, A. O'Duffy, M.R. Gomez, S. Cross, and J.A. Leavitt Risk factors for developing multiple sclerosis after childhood optic neuritis Neurology 49 1997 1413 1418 32
18. M. Matiello, V.A. Lennon, A. Jacob, S.J. Pittock, C.F. Lucchinetti, and D.M. Wingerchuk NMO-IgG predicts the outcome of recurrent optic neuritis Neurology 70 2008 2197 2200
19. ONTT group Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up Arch Neurol 65 2008 727 732
20. C. Papeix, J.S. Vidal, J. de Seze, C. Pierrot-Deseilligny, A. Tourbah, and B. Stankoff Immunosuppressive therapy is more effective than interferon in neuromyelitis optica Mult Scler 13 2007 256 259
21. A. Petzold, S. Pittock, V. Lennon, C. Maggiore, B.G. Weinshenker, and G.T. Plant Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis J Neurol Neurosurg Psychiatry 81 2011 109 111
22. I. Pirko, L.A. Blauwet, T.G. Lesnick, and B.G. Weinshenker The natural history of recurrent optic neuritis Arch Neurol 61 2004 1401 1405
23. S.J. Pittock, V.A. Lennon, J. de Seze, P. Vermersch, H.A. Homburger, and D.M. Wingerchuk Neuromyelitis optica and non organ-specific autoimmunity Arch Neurol 65 2008 78 83
24. J.N. Ratchford, M.E. Quigg, A. Conger, T. Frohman, E. Frohman, and L.J. Balcer Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies Neurology 73 2009 302 308
25. J. Shimizu, Y. Hatanaka, M. Hasegawa, A. Iwata, I. Sugimoto, and H. Date IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum Neurology 75 2010 1423 1427
26. J.T. Tesar, V. Mcmillan, R. Molina, and J. Armstrong Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome Am J Med 92 1992 686 692
27. D.M. Wingerchuk, V.A. Lennon, S.J. Pittock, C.F. Lucchinetti, and B.G. Weinshenker Revised diagnostic criteria for neuromyelitis optica Neurology 66 2006 1485 1489